TZ Ref No.: TZ-1023911

Contract Award Awarded Contract 🌍 International (ICB) Czechia Pharmaceuticals Healthcare and Medicine Chemicals

Antineoplastics and immunomodulators 2026-II Cytostatic drug containing the active substance fruchintinib

Doc ref no. 00622732-2026

Sector Pharmaceuticals, Healthcare and Medicine, Chemicals

Contract Date 11 Sep 2026

Contract Value Undisclosed

Contract Intelligence

AI opportunity notes and scope analysis for this contract award

Opportunity Notes Summarized from official procurement documents

A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.

TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).

Contract Description

Antineoplastics and immunomodulators 2026-II Cytostatic drug containing the active substance fruchintinib
P.o. form s content 1 mg of fruit or vegetables v single form, pre-packaged per year volume 840 single form (dávek); ATC L01EK04

Procurement Requirements & Eligibility

Statutory qualifications, financial guarantees, and bidding compliance.

🛡️

Bid Security / Earnest Money Deposit (EMD)

Exact EMD amount, mandatory bank guarantee format, and validity period extracted from tender notice.

📄

Tender Document Fee & Exemptions

Purchase fees, payment portal coordinates, and MSME/Startup waiver conditions.

🏛️

Financing & Multilateral Rules

Financed by World Bank / ADB / Domestic institutional budgets and governance frameworks.

✅

Bidder Eligibility & Financial Turnover

Minimum 3-year audited turnover threshold, similar contract certificates, and blacklisting declarations.

📦

Bid Submission & DSC Envelopes

Two-envelope digital signing specifications, fee submission deadline, and technical requirements checklist.

Unlock Automated AI Requirement Extraction

Our procurement AI reads the full 50+ page bidding documents to extract verified EMD terms, financial turnover thresholds, exemption criteria, and submission checklists.

Verified EMD Terms Turnover Rules DSC Submission Checklist

Create Free Account to Unlock

Instant free access to all verified procurement criteria • Includes 7-Day Pro Trial

Official Tender Documents

Official bidding notice, specifications, and AI intelligence summary.

3 Available Files

OFFICIAL NOTICE

Official Tender Notice & Bidding Specification VERIFIED SOURCE

TZ Ref: TZ-1023911 • Complete Official Notice Archive

AI BRIEF

AI Executive RFP Summary Brief PRO

Synthesized Executive Intelligence • Key Dates, Budget & Criteria

SOURCE ATTACHMENT

Original Procurement Portal Notice & Attachments

Direct link from Takeda Pharmaceuticals Czech Republic S.r.o.

Open Official Source

Procurement Timeline & Key Deadlines

Notice Published

11 Sep 2026, 00:00

Tender notification officially published to portal

Bidding Window & Clarifications Open

Clarifications window locked

Opening date for submission of queries and tender documents

Submission Deadline

10 Dec 2026, 00:00

Final cutoff for sealed bid submission / e-portal upload

Contract Award Issued

11 Sep 2026

Formal contract award to selected contractor

Unlock Complete Procurement Timeline & Opening Milestones

Get exact pre-bid meeting dates, clarification windows, and official technical bid opening times.

Days to Deadline

53 days

Closing: 10 Dec 2026, 00:00

Key Contract Details

Related Procurement Opportunities

Similar tenders in Pharmaceuticals, Healthcare and Medicine, Chemicals

View all in sector →

Antineoplastics and immunomodulators 2026-II Cytostatic drug containing the active substance fruchintinib

Contract Description

Procurement Requirements & Eligibility

Unlock Automated AI Requirement Extraction

Official Tender Documents

Procurement Timeline & Key Deadlines

Consortium & JV Partners

Key Contract Details

Buyer Contact Information

Related Procurement Opportunities

TenderZenith Assistant

Request Specialist Callback

Antineoplastics and immunomodulators 2026-II Cytostatic drug containing the active substance fruchintinib

Contract Description

Procurement Requirements & Eligibility

Unlock Automated AI Requirement Extraction

Official Tender Documents

Procurement Timeline & Key Deadlines

Consortium & JV Partners

Key Contract Details

Buyer Contact Information

Related Procurement Opportunities

Kitchen management system (V0452/2026)

Delivery of work and protective gloves (V0079/2026)

Küchenmanagement-System (V0452/2026)